For the full presentation, downloadable Practice Aids, slides, and complete NCPD/CE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CCN865. NCPD/CE/AAPA/IPCE credit will be available until May 22, 2026.
Restoring Control in von Willebrand Disease: Collaborative Approaches for Delivering the Right Treatment for the Right Patient at the Right Time
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Bleeding Disorders Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Disclosure information is available at the beginning of the video presentation.
View all episodes
By PVI, PeerView Institute for Medical Education
3.7
33 ratings
For the full presentation, downloadable Practice Aids, slides, and complete NCPD/CE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CCN865. NCPD/CE/AAPA/IPCE credit will be available until May 22, 2026.
Restoring Control in von Willebrand Disease: Collaborative Approaches for Delivering the Right Treatment for the Right Patient at the Right Time
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Bleeding Disorders Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Disclosure information is available at the beginning of the video presentation.
6 Listeners
3 Listeners
10 Listeners
5 Listeners
27 Listeners
9 Listeners
3 Listeners
2 Listeners
5 Listeners
3 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
2 Listeners
10 Listeners
2 Listeners
1,086 Listeners
321 Listeners